Stay updated on Sparsentan in IgA Nephropathy: Clinical Trial

Sign up to get notified when there's something new on the Sparsentan in IgA Nephropathy: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sparsentan in IgA Nephropathy: Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-02T12:58:15.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T15:17:28.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:58:16.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T15:00:04.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the detailed study content with an error screen. Only the minimal header/navigation remains, and the full study information is no longer accessible.
    Difference
    18%
    Check dated 2026-09-21T22:25:48.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, indicating a small system update that replaces the previous v3.6.5. There are no changes to the study details or publicly visible content.
    Difference
    0.0%
    Check dated 2026-08-31T18:28:16.000Z thumbnail image

Stay in the know with updates to Sparsentan in IgA Nephropathy: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sparsentan in IgA Nephropathy: Clinical Trial page.